Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CHRONIC HEPATITIS B”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT03798119
What this trial is testing

TAF Switch in F3/4 CHB pt With Partial Response to NUC (ESTAB-AFPVR)

Who this might be right for
Hepatitis BFibrosis and Cirrhosis of Liver
Kaohsiung Medical University Chung-Ho Memorial Hospital 80
Not applicableStudy completedNCT05669677
What this trial is testing

Study to Determine the Response to COVID-19 Vaccination and Prevalence of COVID-19 in Subjects With Chronic Liver Disease

Who this might be right for
Chronic or Recovered Hepatitis BChronic or Recovered Hepatitis CChronic or Recovered Hepatitis D+2 more
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 233
Early research (Phase 1)Study completedNCT07342868
What this trial is testing

Single-Dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Pevifoscorvir Sodium (ALG-000184) in Subjects With Moderate Hepatic Impairment and in Healthy Subjects With Normal Hepatic Function

Who this might be right for
Chronic Hepatitis B Infections
Aligos Therapeutics 20
Testing effectiveness (Phase 2)Study completedNCT01204762
What this trial is testing

Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen

Who this might be right for
Hepatitis B Virus
Bristol-Myers Squibb 197
Post-approval studies (Phase 4)UnknownNCT03349008
What this trial is testing

Magnesium Isoglycyrrhizinate Followed by Diammonium Glycyrrhizinate and Combined With Entecavir in Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis bLiver Inflammation
Cttq 480
Post-approval studies (Phase 4)Study completedNCT00637663
What this trial is testing

Continuing Lamivudine Versus Switching to Entecavir in Patients Who Achieved Undetectable Hepatitis B Virus DNA

Who this might be right for
Hepatitis B, Chronic
Pusan National University Hospital 72
Post-approval studies (Phase 4)Ended earlyNCT01264133
What this trial is testing

A Study With Clevudine Monotherapy or Adefovir and Clevudine Combination in Patients With Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Bukwang Pharmaceutical 200
Not applicableUnknownNCT02589652
What this trial is testing

Switch or Sequential Combination Therapy of Peginterferon in Hepatitis B Patients With Longterm Entecavir Therapy

Who this might be right for
Chronic Hepatitis B
Huashan Hospital 294
Not applicableStudy completedNCT00155155
What this trial is testing

Studies of Immune Responses in Patients With Chronic Hepatitis B

Who this might be right for
Hepatitis B
National Taiwan University Hospital 100
Not applicableLooking for participantsNCT04896255
What this trial is testing

Long-term Outcomes of Anti-viral Therapies in Patients With Chronic Viral Hepatitis B

Who this might be right for
Chronic Hepatitis b
Huashan Hospital 33,000
Large-scale testing (Phase 3)Study completedNCT00661076
What this trial is testing

ADVANCE Study: A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) + Adefovir Dipivoxil in Patients With Hbe(-) Chronic Hepatitis B

Who this might be right for
Hepatitis B, Chronic
Hoffmann-La Roche 10
Large-scale testing (Phase 3)Study completedNCT01095835
What this trial is testing

Pegylated Interferon Alfa-2a and Lamivudine in Patients With HBeAg-Negative Chronic Hepatitis B Virus (HBV)

Who this might be right for
Hepatitis B, Chronic
Hoffmann-La Roche 131
Not applicableStudy completedNCT00956891
What this trial is testing

Therapeutic Effects of Liver Failure Patients Caused by Chronic Hepatitis B After Autologous MSCs Transplantation

Who this might be right for
Liver FailureMesenchymal Stem Cells
Sun Yat-sen University 158
Not applicableNot Yet RecruitingNCT07777250
What this trial is testing

Targeting ANKRD11 Reverses HBV-Specific CD8+ T Cell Dysfunction and Tolerance

Who this might be right for
Chronic Hepatitis B
Beijing Municipal Administration of Hospitals 40
Post-approval studies (Phase 4)Study completedNCT01743079
What this trial is testing

Study of Telbivudine and Lamivudine to Prevent Vertical Transmission of Hepatitis B

Who this might be right for
Chronic Hepatitis BLate PregnancyTransmission+1 more
Beijing YouAn Hospital 700
Large-scale testing (Phase 3)Study completedNCT01368497
What this trial is testing

Entecavir/Pegylated Interferon in Immune Tolerant Children With Chronic Hepatitis B Virus (HBV) Infection

Who this might be right for
Hepatitis B
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 60
Post-approval studies (Phase 4)Study completedNCT00441974
What this trial is testing

Adefovir Dipivoxil For The Treatment Of Chinese Compensated Chronic Hepatitis B(CHB)Patients

Who this might be right for
Chronic Hepatitis B
GlaxoSmithKline 1,470
Large-scale testing (Phase 3)Ended earlyNCT01641926
What this trial is testing

The Safety and Efficacy of Pegylated Inferferon Alfa-2b (PEG-Intron™) Versus Pegylated Interferon Alfa-2a (PEGASYS™) in Participants With Chronic Hepatitis B (P08450)

Who this might be right for
Hepatitis B, Chronic
Merck Sharp & Dohme LLC 402
Testing effectiveness (Phase 2)UnknownNCT01589952
What this trial is testing

Pegylated Interferon and Entecavir Combination in Chronic Hepatitis B (CHB)

Who this might be right for
Chronic Hepatitis B
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh 20
Not applicableUnknownNCT02581033
What this trial is testing

Determinants of Virological Response After Discontinuation of Nucleoside Analogue Therapy in Hepatitis B Patients

Who this might be right for
Chronic Hepatitis B.
St Vincent's Hospital Melbourne 200
Next Page